Sorry, you need to enable JavaScript to visit this website.

A Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Patients Who Cannot Take Statins (SPIRE-SI)

A Phase 3, Double-Blind, Double-Dummy, Randomized, Placebo and Active Controlled, Parallel-Group Study to Assess the Efficacy, Safety and Tolerability of PF-04950615 in Subjects With Dyslipidemia Who Are Intolerant to Statins]

Category & Conditions: Cardiovasular Diseases and Conditions
Medicine: Bococizumab (PF-04950615) Identifier (NCT): NCT02135029
Protocol ID: B1481030
Open Plain Language Summary Result: Click here